Cargando…
Optical coherence tomography evaluation of pulmonary arterial vasculopathy in Systemic Sclerosis
Our current understanding of the pathophysiology of pulmonary vascular disease is incomplete, since information about alterations of the pulmonary vasculature in pulmonary arterial hypertension (PAH) is primarily provided by autopsy or tissue specimens. The aim of this study was to compare the dista...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324107/ https://www.ncbi.nlm.nih.gov/pubmed/28233825 http://dx.doi.org/10.1038/srep43304 |
_version_ | 1782510155933417472 |
---|---|
author | Schwaiger, Johannes P. Loder, Christopher D. Dobarro, David Kaier, Thomas Reddecliffe, Sally Schreiber, Benjamin E. Handler, Clive Denton, Christopher P. Coghlan, John G. |
author_facet | Schwaiger, Johannes P. Loder, Christopher D. Dobarro, David Kaier, Thomas Reddecliffe, Sally Schreiber, Benjamin E. Handler, Clive Denton, Christopher P. Coghlan, John G. |
author_sort | Schwaiger, Johannes P. |
collection | PubMed |
description | Our current understanding of the pathophysiology of pulmonary vascular disease is incomplete, since information about alterations of the pulmonary vasculature in pulmonary arterial hypertension (PAH) is primarily provided by autopsy or tissue specimens. The aim of this study was to compare the distal pulmonary vasculature of <2 mm in diameter in Systemic Sclerosis (SSc) patients with (n = 17) and without (n = 5) associated PAH using Optical Coherence Tomography during Right Heart catheterization. SSc-PAH patients showed significant thickening of Intima Media Thickening Area compared to patients without PAH (27 +/− 5.8% vs. 21 +/− 1.4%, p = 0.024). A good haemodynamic response to previous targeted PAH treatment was associated with a significantly greater number of small pulmonary artery side branches <300 μm per cm vessel (3.8 +/− 1.1 vs. 1.8 +/− 1.1; p = 0.010) and not associated with Intima Media thickening Area (26 +/− 5.4% vs. 28 +/− 6.7%; p = 0.6). Unexpected evidence of pulmonary artery thrombus formation was found in 19% of SSc-PAH patients. This is the first in-vivo study demonstrating a direct link between a structural abnormality of pulmonary arteries and a response to targeted treatment in PAH. Intravascular imaging may identify subgroups that may benefit from anticoagulation. |
format | Online Article Text |
id | pubmed-5324107 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-53241072017-03-01 Optical coherence tomography evaluation of pulmonary arterial vasculopathy in Systemic Sclerosis Schwaiger, Johannes P. Loder, Christopher D. Dobarro, David Kaier, Thomas Reddecliffe, Sally Schreiber, Benjamin E. Handler, Clive Denton, Christopher P. Coghlan, John G. Sci Rep Article Our current understanding of the pathophysiology of pulmonary vascular disease is incomplete, since information about alterations of the pulmonary vasculature in pulmonary arterial hypertension (PAH) is primarily provided by autopsy or tissue specimens. The aim of this study was to compare the distal pulmonary vasculature of <2 mm in diameter in Systemic Sclerosis (SSc) patients with (n = 17) and without (n = 5) associated PAH using Optical Coherence Tomography during Right Heart catheterization. SSc-PAH patients showed significant thickening of Intima Media Thickening Area compared to patients without PAH (27 +/− 5.8% vs. 21 +/− 1.4%, p = 0.024). A good haemodynamic response to previous targeted PAH treatment was associated with a significantly greater number of small pulmonary artery side branches <300 μm per cm vessel (3.8 +/− 1.1 vs. 1.8 +/− 1.1; p = 0.010) and not associated with Intima Media thickening Area (26 +/− 5.4% vs. 28 +/− 6.7%; p = 0.6). Unexpected evidence of pulmonary artery thrombus formation was found in 19% of SSc-PAH patients. This is the first in-vivo study demonstrating a direct link between a structural abnormality of pulmonary arteries and a response to targeted treatment in PAH. Intravascular imaging may identify subgroups that may benefit from anticoagulation. Nature Publishing Group 2017-02-24 /pmc/articles/PMC5324107/ /pubmed/28233825 http://dx.doi.org/10.1038/srep43304 Text en Copyright © 2017, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Schwaiger, Johannes P. Loder, Christopher D. Dobarro, David Kaier, Thomas Reddecliffe, Sally Schreiber, Benjamin E. Handler, Clive Denton, Christopher P. Coghlan, John G. Optical coherence tomography evaluation of pulmonary arterial vasculopathy in Systemic Sclerosis |
title | Optical coherence tomography evaluation of pulmonary arterial vasculopathy in Systemic Sclerosis |
title_full | Optical coherence tomography evaluation of pulmonary arterial vasculopathy in Systemic Sclerosis |
title_fullStr | Optical coherence tomography evaluation of pulmonary arterial vasculopathy in Systemic Sclerosis |
title_full_unstemmed | Optical coherence tomography evaluation of pulmonary arterial vasculopathy in Systemic Sclerosis |
title_short | Optical coherence tomography evaluation of pulmonary arterial vasculopathy in Systemic Sclerosis |
title_sort | optical coherence tomography evaluation of pulmonary arterial vasculopathy in systemic sclerosis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324107/ https://www.ncbi.nlm.nih.gov/pubmed/28233825 http://dx.doi.org/10.1038/srep43304 |
work_keys_str_mv | AT schwaigerjohannesp opticalcoherencetomographyevaluationofpulmonaryarterialvasculopathyinsystemicsclerosis AT loderchristopherd opticalcoherencetomographyevaluationofpulmonaryarterialvasculopathyinsystemicsclerosis AT dobarrodavid opticalcoherencetomographyevaluationofpulmonaryarterialvasculopathyinsystemicsclerosis AT kaierthomas opticalcoherencetomographyevaluationofpulmonaryarterialvasculopathyinsystemicsclerosis AT reddecliffesally opticalcoherencetomographyevaluationofpulmonaryarterialvasculopathyinsystemicsclerosis AT schreiberbenjamine opticalcoherencetomographyevaluationofpulmonaryarterialvasculopathyinsystemicsclerosis AT handlerclive opticalcoherencetomographyevaluationofpulmonaryarterialvasculopathyinsystemicsclerosis AT dentonchristopherp opticalcoherencetomographyevaluationofpulmonaryarterialvasculopathyinsystemicsclerosis AT coghlanjohng opticalcoherencetomographyevaluationofpulmonaryarterialvasculopathyinsystemicsclerosis |